Copyright © 2006 Elsevier Ltd All rights reserved.
Brief communication
Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme
Received 30 January 2006;
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
12(S)-Lipoxygenase (LOX) is regarded as a pro-tumorigenic enzyme and as a potential target for therapy and prevention of cancer so that the search for specific 12(S)-LOX inhibitors is part of drug development strategies. To facilitate the identification of specific 12(S)-LOX inhibitors we have created an assay cell line by introducing a12(S)-LOX expression vector into SW480 colorectal cancer cells. When arachidonic acid was supplied in the medium both transiently and stably overexpressing cells produced 12(S)-hydroxytetraenic acid (HETE) originating from the transfected gene at 4–5-fold the amount obtained from control transfectants. 12(S)-HETE production was 1913.7 ± 17.2 pg/ml and reached a steady state level 24 h after addition of arachidonic acid. To demonstrate the models suitability of 12(S)-LOX overexpressing SW480 cells they were used to measure the inhibitory activity of the plant phenols baicalein, kaempferol, quercetin, nordihydroguaretic acid and resveratrol which are known for their chemopreventive as well as LOX-inhibitory activity in different tumour models. All 5 compounds inhibited 12(S)-HETE production at concentrations below those necessary for growth inhibition.
Keywords: 12(S)-Lipoxygenase; 12(S)-HETE, ELISA
Abbreviations: AA, arachidonic acid; CDC, cinnamyl-3,4-dihydroxy-α-cyanocinnamate; COX, cyclooxygenase; FCS, foetal calf serum; FACS, fluorescence activated cell sorter; GFP, green fluorescence protein; HETE, hydroxytetraenic acid; LOX, lipoxygenase; MEM, minimal essential medium; PG, prostaglandin
Article Outline
- 1. Introduction
- 2. Materials and methods
- 2.1. Cell lines and transfection
- 2.2. LOX enzyme gene expression
- 2.3. 12(S)-HETE ELISA
- 2.4. Compounds
- 2.5. Cell number and induction of apoptosis
- 2.6. Calculation of LOX-inhibitory activity
- 3. Results
- 3.1. Expression of LOX-enzymes in colorectal tumour cells
- 3.2. Overexpression of 12(S)-LOX in SW480 cells
- 3.3. Activity of plant constituents
- 4. Discussion
- Acknowledgements
- References






E-mail Article
Add to my Quick Links

Cited By in Scopus (3)






